Statements and Guidelines
RANZCOG is dedicated to providing trusted, independent and evidence-based to support clinical practice in obstetrics and gynaecology across Australia and Aotearoa New Zealand. Please see the RANZCOG Clinical Guidance, RANZCOG Endorsed, RANZCOG Statements, and Relevant External Resources below.
| Title | Notes | Category | Type | View | hf:tax:statement-guideline-type | hf:doc_categories | hf:tax:statement-guideline-tag |
|---|---|---|---|---|---|---|---|
| A Practitioner’s Toolkit for Managing Menopause (Monash University) | Gynaecology | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | |||
| Antenatal Corticosteroids Given to Women Prior to Birth to Improve Fetal, Infant, Child and Adult Health (Liggins Institute) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | |||
| Assessment of Competency (C-Gen 9) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Birth After Caesarean (C-Obs 38) | August 2025 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | bac nbac next-birth-after-caesarean repeat-caesarean-birth tolac trial-of-labour-after-caesarean uterine-rupture-risk vbac | |
| Caesarean Birth on Maternal Request CBMR (C-Obs 39) | 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | birth-planning decision-making elective-caesarean perioperative-care planned-caesarean surgical-delivery | |
| Care in Labour in the Absence of Pregnancy Complications (C-Obs 31) | 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | intrapartum-monitoring labour-progression midwifery-led-care normal-birth oxytocin pain-relief physiological-labour sepsis supportive-care ultrasound | |
| Categorisation of Urgency for Caesarean Section (C-Obs 14) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | emergncy-caesarean fetal-compromise intrapartum surgical-prioritisation | |
| Cervical Cancer Screening in Australia and Aotearoa New Zealand (C-Gyn 19) | Signposting 2024 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | cancer-prevention cervical-dysplasia colposcopy cytology hpv-screening hpv-testing | |
| Clinical Guideline for Abortion Care | 2023 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | anti-d antibiotic-prophylaxis dc decision-aid dilatation-and-curettage early-medical-abortion ema medical-abortion pregnancy-termination rh-d-testing sepsis surgical-abortion telehealth-abortion ultrasound | |
| Care Around Stillbirth and Neonatal Death Clinical Practice Guideline (Stillbirth CRE & PSANZ) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Clinical Handover (WPI 19) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Clinical Training Whilst Pregnant (C-Trg 7) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | |||
| Communication Between Eligible Midwives and Obstetricians (GP or Specialist) (ACM) | General | Relevant External Resource | useful-clinical-guidance | statements-guidelines-general statements-guidelines | |||
| Contraception Clinical Guideline (C-Gyn 3) | 2024 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | ablation contraceptive-counselling emergency-contraception fertility-control hormonal-contraception intrauterine-devices long-acting-reversible-contraception reproductive-planning tubal-ligation | |
| Cross-Border Reproductive Care (C-Gyn 36) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | access-to-care assisted-reproduction donor-gametes ethical-considerations fertility-tourism ivf regulatory-differences surrogacy | |
| Credentialing in Obstetrics and Gynaecology (WPI 23) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Cultural Competency (WPI 20) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Delivery of Fetus at Caesarean Birth (C-Obs 37) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | fetal-head-delivery intraoperative-complications maternal-safety obstetric-surgery operative-techniques surgical-extraction training-skills | |
| Decision Aids to Accompany Fatigue Risk Management in Obstetric and Gynaecological Practice (WPI 18) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Cultural Safety Statement of Intent | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Diagnosis and Management of Suspected Fetal Macrosomia (C-Obs 65) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | diabetes-risk fetal-growth-assessment fetal-monitoring induction large-for-gestational-age risk-assessment shoulder-dystocia ultrasound | |
| Early Pregnancy Screening and Prevention of Preterm Preeclampsia and Related Complications (C-Obs 61) | 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | antenatal-corticosteroids cervical-length-assessment fetal-fibronectin high-blood-pressure high-risk-pregnancy hypertension neonatal-care perinatal preterm-labour-risk progesterone-therapy risk-assessment screening tocolysis ultrasound | |
| Driving after Abdominal Surgery Including Caesarean Section (C-Gen 21) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Australian Living Evidence Guideline: Endometriosis | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | ablation adenomyosis dysmenorrhoea endometrioma excision heavy-menstrual-bleeding heavy-periods hysterectomy infertility laparoscopy pelvic-pain screening ultrasound | ||
| Exercise During Pregnancy (C-Obs 62) | 2020 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | antenatal cardiovascular fitness gestational-weight maternal-risk neonatal-care pelvic-floor perinatal-exercise perinatal-physical-activity postpartum-recovery | |
| Fatigue Risk Management in Obstetric and Gynaecological Practice (WPI 18) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Evidence-based Medicine, Obstetrics and Gynaecology (C-Gen 15) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies (SOGC) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | |||
| Female Genital Mutilation (FGM) (C-Gyn 1) | 2023 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | cultural-health-practices female-genital-cutting fgc infection maternal-health obstetric-complications perineal-reconstruction postpartum risk-assessment sexual-health-impacts trauma-informed-care | |
| Genetic Carrier Screening (C-Obs 63) | Interim Update Jul 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | 3-gene-panel cystic-fibrosis fragile-x-syndrome genetic-risk infertility inherited-conditions neonatal-care pan-ethnic-carrier-screening partner-testing pre-pregnancy-screening prenatal-decision-making recessive-disorders reproductive-carrier-screening reproductive-planning risk-assessment spinal-muscular-atrophy | |
| Fibroids in Infertility (C-Gyn 27) | 2018 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | assisted-reproduction hysteroscopy implantation-failure infertility laparoscopy myomectomy pelvic-mass reproductive-outcomes risk-assessment screening submucosal-fibroids uterine-myomas | |
| Guidance for Healthy Weight Gain in Pregnancy (Ministry of Health NZ) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | |||
| Guidelines for Human Papillomavirus (HPV) Vaccine (C-Gyn 18) | Signposting 2024 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | cervical-cancer-prevention cervical-screening immunisation-schedule infection maternal-health neonatal-care risk-assessment vaccination | |
| Guidelines for Appointment of Obstetricians and Gynaecologists to Specialist Positions in Australia and New Zealand (WPI 17) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Guidelines for the Use of Rh(D) Immunoglobulin (Anti-D) in Obstetrics (C-Obs 6) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | alloimmunisation-prevention antenatal-antibodies blood-group haemolytic-disease maternal-health neonatal-care postpartum-prophylaxis prophylactic-injections risk screening sensitising-events | |
| Guidelines for Performing Gynaecological Endoscopic Procedures (C-Trg 2) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | |||
| Guidelines for Patient Record Management on the Discontinuation of Practice (WPI 8) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Guidelines for Scanning of Live Subjects for Teaching Purposes (WPI 21) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Gynaecological Examinations and Procedures (C-Gyn 30) | 2020 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | anatomical-landmark cervical-examination clinical-procedure consent hysteroscopy laparoscopy maternal-health outpatient-procedure pelvic-assessment pelvic-floor risk-assessment speculum | |
| Guidelines for Training in Advanced Endoscopic Surgery (C-Trg 1) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | |||
| Guidelines for Visiting Surgeons Conducting Demonstration Sessions (C-Gen 6) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Home Births (C-Obs 2) | 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | birth-plan community-birth emergency-contingency-planning labour-support midwifery-led-care neonatal-safety planned-birth risk-assessment transfer-protocols | |
| Instrumental Vaginal Birth (C-Obs 16) | 2020 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | fetal-head-position fetal-monitoring forceps-delivery neonatal-care neonatal-monitoring operative-vaginal-indications perineal-trauma risk-assessment second-stage-management vacuum-extraction | |
| Intrahepatic Cholestasis of Pregnancy (RCOG Green-top Guideline No. 43) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | |||
| Interview and Selection of Obstetricians and Gynaecologists for Visiting Medical Officers, Salaried Medical Officers and Academic Staff in Australia (WPI 4) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Intrapartum Fetal Surveillance (IFS) (C-Obs 1) (Version 5.1) | March 2026 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | cardiotocography ctg doppler fbs fetal-blood-sampling fetal-scalp-stimulation fetal-surveillance-education-program fsep fss ia intermittent-auscultation monitoring-baby-during-labour pinard risk-assessment tocolysis ultrasound umbilical-cord-blood-sampling uterine-hyperstimulation | |
| Investigation of Intermenstrual and Postcoital Bleeding (C-Gyn 6) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | abnormal-uterine-bleeding aub cervical-pathology colposcopy dc dilation-and-curettage heavy-menstrual-bleeding heavy-periods hormonal-disorders hysteroscopy pelvic-ultrasound screening | |
| Joint RANZCOG/ANZCA/RACGP Position Statement on the Provision of Obstetric Anaesthesia and Analgesia Services (WPI 14) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Locum Positions in Specialist Obstetric and Gynaecological Practice in Australia and New Zealand (WPI 12) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Management of Breech Presentation (C-Obs 11) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | birth-planning bottom-first ecv external-cephalic-version feet-first fetal-positioning intrapartum-criteria mode-of-birth risk-assessment vaginal-breech-birth | |
| Management of Gestational Trophoblastic Disease (C-Gyn 31) | 2017 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | chemotherapy choriocarcinoma fertility-preservation follow-up hcg-monitoring molar-pregnancy surveillance tumour-monitoring uterine-evacuation | |
| Management of Hepatitis C in Pregnancy (C-Obs 51) | 2020 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | antiviral-therapy blood-borne-viruses breastfeeding hep-c infection liver-function neonatal-testing obstetric-precautions vertical-transmission-risk viral-transmission | |
| Management of Monochorionic Twin Pregnancy (C-Obs 42) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | chorionicity-assessment fetal-complications fetal-monitoring neonatal-care preterm-birth-risk risk-assessment selective-growth-restriction serial-ultrasound twin-monitoring-protocols twin-to-twin-transfusion | |
| Management of Obesity in Pregnancy (C-Obs 49) | 2022 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | anaesthetic-considerations bmi diabetes fetal-growth-issues gestational-weight-gain hypertension labour-management maternal-health metabolic-complications screening-protocols | |
| Management of Perinatal Infections (ASID) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Management of Postpartum Haemorrhage (PPH) (C-Obs 43) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | active-third-stage blood-loss haemostatic-therapies heavy-bleeding labour massive-transfusion obstetric-emergency oxytocin surgical-interventions uterine-atony | |
| Managing Menopausal Symptoms (C-Gyn 9) | Under Review 2020 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | genitourinary gus hormone-therapy hot-flush hrt mht night-sweats urogenital vasomotor vms | |
| Maternal and Perinatal Data Collection (C-Obs 40) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | clinical-indicators data-standards hospital-reporting national-benchmarking obstetric-outcomes perinatal-epidemiology quality-improvement | |
| Maternal Group B Streptococcus in Pregnancy Screening and Management (C-Obs 19) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | antibiotics colonisation-risk early-onset-infection infection neonatal-sepsis obstetric-protocols prevention-strategies vaginal-rectal-swab | |
| Managing the Adnexa at the Time of Hysterectomy for Benign Gynaecological Disease (C-Gyn 25) | 2023 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | adnexal-cyst adnexal-surgery adnexal-tumor bgd fallopian-tube hysterectomy hysteroscopy laparoscopy ovarian-conservation ovaries pelvic-anatomy salpingectomy surgery | |
| Measurement of Cervical Length for Prediction of Preterm Birth (C-Obs 27) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | cerclage-selection fetal-fibronectin funneling high-risk-pregnancy preterm-prediction progesterone-therapy screening short-cervix ultrasound | |
| Obstetric and Gynaecology Services in Rural and Remote Regions in Australia (C-Obs 34) | 2020 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | access barrier distance emergency-retrieval equity service telehealth training workforce-shortage | |
| Placenta Accreta Spectrum (PAS) (C-Obs 20) | 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | abnormal-placentation antenatal-imaging complex-caesarean haemorrhage multidisciplinary-care placenta-percreta placental-invasion risk-assessment surgical-planning ultrasound | |
| International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (PCOS) | Gynaecology | Relevant External Resource | useful-clinical-guidance | statements-guidelines-gynaecology statements-guidelines | |||
| Performance of Sexual Assault Forensic Examinations by RANZCOG Trainees (C-Gen 12) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Polypropylene Vaginal Mesh Implants for Vaginal Prolapse (C-Gyn 20) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | hysterectomy laparoscopy pelvic-floor pelvic-organ-prolapse surgery urogynaecology | |
| Position Statement on Midurethral Slings (C-Gyn 32) | 2020 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | continence-surgery pelvic-floor prolapse risk-assessment stress-incontinence synthetic-mesh urinary-incontinence urodynamic-consideration | |
| Position Statement on Breastfeeding and Lactation in the Workplace | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Robotic Assisted Surgery in Gynaecology, Urogynaecology and Gynae-oncology (C-Gyn 29) | March 2026 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | hysterectomy laparoscopy minimally-invasive-surgery operation surgical technology training | |
| Power Morcellation at Minimally Invasive Procedures (C-Gyn 33) (Previously “Tissue Extraction”) | 2022 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | hysterectomy laparoscopy occult-malignancy-risk perioperative safety specimen-containment surgery tissue-extraction uterine-fibroids | |
| Position Statement on the Appropriate Use of Diagnostic Ultrasound (C-Gen 10) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Pre-Pregnancy and Pregnancy Related Vaccinations (C-Obs 44) | Signposting Interim Update Oct 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | antenatal-immunology breastfeeding fetal-protection immune immunisation influenza-vaccine live-vaccine maternal-antibodies pertussis-prevention preventable-disease risk-assessment | |
| Pre-Pregnancy Counselling (C-Obs 3a) | 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | antenatal-preparation bmi chronic-disease-optimisation contraception diabetes fertility-expectations genetic-risk-discussion lifestyle-modification medication-review ovulation pre-conception preventable-disease reproductive-planning travel | |
| Prevention and Management of Postpartum Haemorrhage (RCOG Green-top Guideline No. 52) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | |||
| Prevention of Congenital Cytomegalovirus (CMV) Infection (C-Obs 64) | Interim Update July 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | childcare-exposure congenital-infection hygiene-measures mother-to-child-transmission mtct neonatal-outcomes pregnancy-precautions serology-testing viral-transmission | |
| Prevention, Detection, and Management of Subgaleal Haemorrhage in the Newborn (C-Obs 28) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | head-swelling hypovolaemia neonatal resuscitation risk scalp-injury vacuum-extraction | |
| Progesterone Use in the Second and Third Trimester of Pregnancy for the Prevention of Preterm Birth (C-Obs 29b) | 2017 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | cervical-insufficiency high-risk-pregnancy hormonal-therapy luteal-support | |
| Prophylactic Antibiotics in Obstetrics and Gynaecology (C-Gen 17) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | dc dilation-and-curettage infection-prevention laparoscopy perioperative-protocols procedure sepsis surgery | |
| RANZCOG Training Registrar Supervision Guideline (C-Trg 5) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | |||
| RANZCOG Position Statement Health of Women Seeking Asylum, Refugees and Women Held in Detention | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| RANZCOG Wellbeing Position Statement | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Responsibility for Neonatal Resuscitation at Birth (C-Obs 32) | Interim Update Mar 2023 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | airway-support apgar-response hypoxia-management intrapartum newborn-transition protocol thermal-regulation | |
| Reproductive Health for Women with an Intellectual Disability (C-Gyn 10) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | consent contraception decision-making sexual-education supported-care | |
| Routine Antenatal Assessment in the Absence of Pregnancy Complications (C-Obs 3b) | 2022 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | amniocentesis antenatal-schedule anti-d aph blood-pressure monitoring pregnancy-risk-factors screening | |
| Screening and Diagnosis of Fetal Structural Anomalies and Chromosome Conditions (C-Obs 35) | 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | amniocentesis aneuploidies anomaly cfts chromosomal-microarray cvs first-trimester-combined-screening genetic-counselling genetic-testing nipt non-invasive-prenatal-testing prenatal-assessment prenatal-diagnosis scan second-trimester-maternal-serum-screening standard-karyotype structural-conditions structural-defects ultrasound | |
| Sacrocolpopexy Clinical Guidance Statement (C-Gyn 37) | 2022 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | graft mesh-repair pelvic-organ-prolapse urogynaecology vaginal-prolapse vault-suspension | |
| Shoulder Dystocia (RCOG Green-top Guideline No. 42) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | |||
| Semi-Retired RANZCOG Fellow (WPI 24) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Shared Maternity Care in Australia (WPI 9) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Sexuality-Related Communication (WHO) | General | Relevant External Resource | useful-clinical-guidance | statements-guidelines-general statements-guidelines | |||
| Stand-Alone Primary Midwifery-Led Units (WPI 15) | Workforce and Practice Issues | RANZCOG Statements | ranzcog-statements | statements-guidelines-workforce statements-guidelines | |||
| Statement on Climate Change (2019) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Statement on Prolonged Exposure to Bushfire Smoke and Poor Air Quality (2020) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Subclinical Hypothyroidism and Hypothyroidism in Pregnancy (C-Obs 46) | 2022 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | endocrine-disorders evothyroxine fetal-neurodevelopment pregnancy-metabolism thyroid-dysfunction tsh-monitoring | |
| Substance Use in Pregnancy Clinical Guideline (C-Obs 53) | 2024 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | abstinence alcohol cannabis dependency exposure harm-reduction maternal-fetal-medicine neonatal-abstinence neonatal-harms nicotine opioid-use polysubstance-use pre-pregnancy-counselling prevention screening smoking | |
| Term Prelabour Rupture of Membranes (Term PROM) (C-Obs 36) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | gbs induction infection intrapartum labour-onset maternal-monitoring prelabour | |
| Tamoxifen and the Endometrium (C-Gyn 12) | 2019 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | abnormal-bleeding endometrial-thickening hormone hyperplasia hysteroscopy pelvic-floor surveillance | |
| Surrogacy in Australia and New Zealand (C-Gen 16) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| The Initial Management of Chronic Pelvic Pain (RCOG Green-top Guideline No. 41) | Gynaecology | Relevant External Resource | useful-clinical-guidance | statements-guidelines-gynaecology statements-guidelines | |||
| The Management of Third and Fourth Degree Perineal Tears (RCOG Green-top Guideline No. 29) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | |||
| The Management of Women with Red Cell Antibodies During Pregnancy (RCOG Green-top Guideline No. 65) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | |||
| The Prevention and Elimination of Disrespect and Abuse During Facility-based Childbirth (WHO) | General | Relevant External Resource | useful-clinical-guidance | statements-guidelines-general statements-guidelines | |||
| Timing of Planned Caesarean Section at Term (C-Obs 23) | 2022 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | caesarean-birth delivery-planning elective-caesarean-caesarean-section elective-surgery gestational-age-selection maternal-considerations morbidity perioperative-optimisation surgical-scheduling | |
| Umbilical Cord Prolapse (RCOG Green-top Guideline No. 50) | Obstetrics | Relevant External Resource | useful-clinical-guidance | statements-guidelines-obstetrics statements-guidelines | |||
| Use of Prostaglandins for Induction of Labour (C-Obs 22) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | cervical-ripening induction labour-augmentation labour-ripening oxytocin protocols uterine-contractility | |
| Use of Lasers in Obstetrics and Gynaecology (C-Trg 4) | Training | RANZCOG Statements | ranzcog-statements | statements-guidelines-training statements-guidelines | |||
| Use of the Veress Needle to Obtain Pneumoperitoneum Prior to Laparoscopy (C-Gyn 7) | 2021 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | abdominal-insufflation complication-avoidance hysterectomy laparoscopic-access minimally-invasive-entry operative-setup surgical-access surgical-safety trocar-technique | |
| Uterine Artery Embolisation for the Treatment of Uterine Fibroids (C-Gyn 23) | 2020 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | infertility interventional-radiology pelvic-pain | |
| Vaginal Rejuvenation and Cosmetic Vaginal Procedures (C-Gyn 24) | 2019 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | cosmetic-surgery genital labiaplasty regulatory | |
| Vasa Praevia (C-Obs 47) | July 2025 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | antenatal-surveillance caesarean-planning complication doppler fetal-vessel haemorrhage low-lying low-lying-placenta pregnancy ultrasound velamentous-cord-insertion | |
| Vitamin and Mineral Supplementation and Pregnancy (C-Obs 25) | 2019 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | dietary-requirements iron-deficiency nutrition prenatal supplementation | |
| Water Immersion During Labour and Birth (C-Obs 24) | 2021 | Obstetrics | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-obstetrics statements-guidelines | waterbirth | |
| Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38) | 2025 | Gynaecology | RANZCOG Clinical Guidance | ranzcog-clinical-guideline | statements-guidelines-gynaecology statements-guidelines | anti-d aps apss asherman-syndrome dc dilation-and-curettage early-pregnancy-loss progesterone sepsis ultrasound | |
| Australasian Diabetes in Pregnancy Society (ADIPS) 2025 Consensus Recommendations for the Screening, Diagnosis and Classification of Gestational Diabetes | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Guideline on the Prophylactic Use of Rh-D Immunoglobin in Pregnancy Care | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Perinatal Mental Health Clinical Practice Guideline (Centre of Perinatal Excellence – COPE) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Position Statement: Reusable Surgical Gowns (Royal Australasian College of Surgeons) | Gynaecology, Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines-obstetrics statements-guidelines | |||
| Clinical Guideline: Smoking Cessation in Pregnancy and Breastfeeding (Quit Victoria) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Hypertension in Pregnancy Guideline (SOMANZ) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Guideline on Procedural Sedation (ANZCA) | Gynaecology, Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines-obstetrics statements-guidelines | |||
| Cervical Screening Guidelines and Endorsement (Cancer Council Australia) | Gynaecology | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | |||
| Managing Infant Formula Donations, Procurement and Distribution in Emergencies (Australian Breastfeeding Association) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Vitamin D Deficiency Guideline (Te Whatu Ora) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| National Recommendations for Rare Disease Health Care (Rare Disease Awareness, Education, Support and Training RArEST Project) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Australian Evidence-Based Guideline for Unexplained Infertility (NHMRC) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Clinical Indications for Pharmacogenomic Testing (RCPA) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Guideline for Newborn Screening for Spinal Muscular Atrophy (UNSW) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Assessment and Management of Abnormal Uterine Bleeding (AUB) in Non-Pregnant Women of Reproductive Age (Health New Zealand – Te Whatu Ora) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| ARF/RHD Guidelines (Menzies School for Health Research) | Gynaecology | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | |||
| Premature Ovarian Insufficiency Guideline (ESHRE) | Gynaecology | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines | |||
| Anti-Mullerian Hormone (AMH) Testing (University of Sydney) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Supporting Diverse Families: Clinical Staff Resources (Red Nose) |
| Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | ||
| Clinical Practice Guideline for Neonatal Hypoglycaemia (University of Auckland) | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Implanon NXT® (etonogestrel) Subdermal Implant Training Recommendations for Healthcare Professionals in Australia |
| Gynaecology, Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-gynaecology statements-guidelines-obstetrics statements-guidelines | ||
| Australian Clinical Guidelines on HTLV-1 for Aboriginal Primary Health Care Settings | Obstetrics | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-obstetrics statements-guidelines | |||
| Clinical Standards For Australian Secondary Fracture Prevention Services (SOSFA) | General | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-general statements-guidelines | |||
| Volunteering or Working in Women’s Healthcare in Low- and Middle-Income Countries (C-Gen 22) | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | |||
| Statement on Decommissioning Nitrous Oxide Medical Gas Pipeline Systems | General | RANZCOG Endorsed | ranzcog-endorsed | statements-guidelines-general statements-guidelines | |||
| Consent and Provision of Information to Patients Regarding Proposed Treatment (C-Gen 2) | June 2026 | General | RANZCOG Statements | ranzcog-statements | statements-guidelines-general statements-guidelines | consent consent-to-medical-intervention consent-to-medical-procedure duty-to-inform informed-choice informed-consent patient-consent |
About our statements and guidelines
RANZCOG is dedicated to providing trusted, independent, and evidence-based guidance in women’s health across Australia and Aotearoa New Zealand. Evidence-based clinical guidelines are central to the delivery of high-quality health care as they define standards of care, support professional consistency, and uphold quality and safety.
RANZCOG offers a range of resources intended to support clinical practice in obstetrics and gynaecology. These resources are provided for general informational purposes and should be applied in the context of individual clinical judgement and patient circumstances.
If you have a suggestion for a new guideline topic, you can submit it via our nomination form.
Alongside our clinical guidance, you’ll also find resources on training, workforce and practice Issues, as well as documents currently endorsed by RANZCOG and selected external materials.
Types of statements and guidelines
Disclaimer
RANZCOG reviews clinical guidelines, statements, and patient information pamphlets on a five-year rotation, notwithstanding special circumstances. The number of documents that require review in any given year is large, and on occasion RANZCOG may be unable to complete all reviews within the designated time frame. Some of these documents will not require updating at the time they are reviewed. In these cases, the version date and the year for next review will be updated, but the content remains unchanged.
The ‘due for review date’ on a document is an administrative tool that helps RANZCOG to keep track of its information resources. It does not mean that the information is no longer relevant once the review date has passed. The information within these documents does not expire, however changes to treatments, practices and advice may occur over time, which is why RANZCOG regularly reviews and updates them (if necessary). The information provided in these documents is of a general nature and is not intended to be a substitute for medical advice, diagnosis or treatment by a qualified health professional. An individual’s specific circumstances should always be considered when medical decisions are made.
To the maximum extent permitted by law, RANZCOG does not warrant the accuracy, completeness or currency of the information and is not liable for any loss or damage arising from reliance on this information.
RANZCOG will prioritise information for review if the circumstances warrant it.
Request archived documents
Complete the request form for archived statements and guidelines. Please note that requests can take 5-10 days to complete.